<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US7871404 - System and method for treating connective tissue - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_4ff636b3d23669b7103f3b3a3a18b4cd/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_4ff636b3d23669b7103f3b3a3a18b4cd__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="System and method for treating connective tissue"><meta name="DC.contributor" content="Annmarie Hipsley" scheme="inventor"><meta name="DC.contributor" content="Annmarie Hipsley" scheme="assignee"><meta name="DC.date" content="2006-3-15" scheme="dateSubmitted"><meta name="DC.description" content="A method and system of treating connective tissue to alter the biomechanical and fundamental properties of the connective tissue by forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved in the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue. The connective tissue may be any desired connective tissue. The connective tissue of the eye may be removed to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the corneal center of the eye. Connective tissue is removed from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the corneal center of the eye."><meta name="DC.date" content="2011-1-18" scheme="issued"><meta name="DC.relation" content="US:20010016736:A1" scheme="references"><meta name="DC.relation" content="US:20010029363:A1" scheme="references"><meta name="DC.relation" content="US:20030028228:A1" scheme="references"><meta name="DC.relation" content="US:20030059755:A1" scheme="references"><meta name="DC.relation" content="US:20030220630:A1" scheme="references"><meta name="DC.relation" content="US:20050107774:A1" scheme="references"><meta name="DC.relation" content="US:20050205101:A1" scheme="references"><meta name="DC.relation" content="US:20050279369:A1" scheme="references"><meta name="DC.relation" content="US:20070225631:A1" scheme="references"><meta name="DC.relation" content="US:5354331" scheme="references"><meta name="DC.relation" content="US:5653730" scheme="references"><meta name="DC.relation" content="US:6254600" scheme="references"><meta name="DC.relation" content="US:6263879" scheme="references"><meta name="citation_patent_number" content="US:7871404"><meta name="citation_patent_application_number" content="US:11/376,969"><link rel="canonical" href="http://www.google.com/patents/US7871404"/><meta property="og:url" content="http://www.google.com/patents/US7871404"/><meta name="title" content="Patent US7871404 - System and method for treating connective tissue"/><meta name="description" content="A method and system of treating connective tissue to alter the biomechanical and fundamental properties of the connective tissue by forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved in the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue. The connective tissue may be any desired connective tissue. The connective tissue of the eye may be removed to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the corneal center of the eye. Connective tissue is removed from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the corneal center of the eye."/><meta property="og:title" content="Patent US7871404 - System and method for treating connective tissue"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("hqfpU6HmCtProASQ3YAo"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407464522.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("AUS"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("hqfpU6HmCtProASQ3YAo"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407464522.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("AUS"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us7871404?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US7871404"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=pwC4BgABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS7871404&amp;usg=AFQjCNGSrkGGzFFoExX31iMCVi5EteU6ng" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US7871404.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US7871404.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20070016175"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US7871404"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US7871404" style="display:none"><span itemprop="description">A method and system of treating connective tissue to alter the biomechanical and fundamental properties of the connective tissue by forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue....</span><span itemprop="url">http://www.google.com/patents/US7871404?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US7871404 - System and method for treating connective tissue</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US7871404 - System and method for treating connective tissue" title="Patent US7871404 - System and method for treating connective tissue"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US7871404 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 11/376,969</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Jan 18, 2011</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Mar 15, 2006</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Mar 15, 2005</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2605018A1">CA2605018A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US8348932">US8348932</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20070016175">US20070016175</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20110190798">US20110190798</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20120165849">US20120165849</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2006099594A2">WO2006099594A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO2006099594A3">WO2006099594A3</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">11376969, </span><span class="patent-bibdata-value">376969, </span><span class="patent-bibdata-value">US 7871404 B2, </span><span class="patent-bibdata-value">US 7871404B2, </span><span class="patent-bibdata-value">US-B2-7871404, </span><span class="patent-bibdata-value">US7871404 B2, </span><span class="patent-bibdata-value">US7871404B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Annmarie+Hipsley%22">Annmarie Hipsley</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Annmarie+Hipsley%22">Annmarie Hipsley</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US7871404.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7871404.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7871404.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (13),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (13),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (6)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/7871404&usg=AFQjCNHnki5WCpLnHJFBxpAUGgs98D0zsQ">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D7871404&usg=AFQjCNGG3W6f7ZjZ71pCFXALJI92gO42Jw">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D7871404B2%26KC%3DB2%26FT%3DD&usg=AFQjCNF57hEnR-oj2pKkZKRWpkMHT9u_cA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT99952004" lang="EN" load-source="patent-office">System and method for treating connective tissue</invention-title></span><br><span class="patent-number">US 7871404 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA82207426" lang="EN" load-source="patent-office"> <div num="p-0001" class="abstract">A method and system of treating connective tissue to alter the biomechanical and fundamental properties of the connective tissue by forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved in the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue. The connective tissue may be any desired connective tissue. The connective tissue of the eye may be removed to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the corneal center of the eye. Connective tissue is removed from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the corneal center of the eye.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(3)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7871404B2/US07871404-20110118-D00000.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7871404B2/US07871404-20110118-D00000.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7871404B2/US07871404-20110118-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7871404B2/US07871404-20110118-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7871404B2/US07871404-20110118-D00002.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7871404B2/US07871404-20110118-D00002.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(15)</span></span></div><div class="patent-text"><div mxw-id="PCLM34223324" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text">1. A method of affecting the biomechanical properties of an eye having scleral tissue, having a surface, the method comprising:
<div class="claim-text">forming a first closely arranged, two-dimensional array of pores on the surface of the scleral tissue, wherein the two-dimensional array of pores has an outline that forms a polygonal shape on the surface of the scleral tissue; wherein the pores have inner walls that are spaced a distance from each another; and</div>
<div class="claim-text">at least partially affecting normal healing of the pores.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text">2. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref> including filling the pores with a substance that at least partially affects normal healing of the pores.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text">3. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref> including filling the pores with a porous collagen-based scaffold.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text">4. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref> including filling the pores with a sealant.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00005" num="00005" class="claim">
      <div class="claim-text">5. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the eye has a posterior surgical limbus having an outer diameter and wherein the two-dimensional array of pores is formed at a first distance that is less than or equal to 1 mm from the outer diameter of the posterior surgical limbus of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00006" num="00006" class="claim">
      <div class="claim-text">6. The method as set forth in <claim-ref idref="CLM-00005">claim 5</claim-ref>, further comprising forming a second closely arranged, two dimensional array of pores on the surface of the scleral tissue at a second distance that is greater than or equal to 1 mm and less than or equal to 4.5 mm from the outer diameter of the posterior surgical limbus of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00007" num="00007" class="claim">
      <div class="claim-text">7. The method as set forth in <claim-ref idref="CLM-00005">claim 5</claim-ref> further comprising forming a third closely arranged, two dimensional array of pores on the surface of the scleral tissue at a third distance from the outer diameter of the posterior surgical limbus of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00008" num="00008" class="claim">
      <div class="claim-text">8. The method as set forth in <claim-ref idref="CLM-00007">claim 7</claim-ref> wherein the third distance is greater than or equal to 4.5 mm from the outer diameter of the posterior surgical limbus of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00009" num="00009" class="claim">
      <div class="claim-text">9. The method as set forth in <claim-ref idref="CLM-00007">claim 7</claim-ref> including forming the first, second and third closely arranged, two-dimensional array of pores in a radial line extending from the corneal center of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00010" num="00010" class="claim">
      <div class="claim-text">10. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the first closely arranged, two-dimensional array of pores forms at least one of the following: a rectangular matrix, a square matrix, a diamond matrix, or a central hexagonal matrix.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00011" num="00011" class="claim">
      <div class="claim-text">11. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the first closely arranged, two-dimensional array of pores is located on the posterior portion of the eye.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00012" num="00012" class="claim">
      <div class="claim-text">12. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein each pore has inner walls, and wherein the inner walls are spaced from each other by a distance greater than 400 μm.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00013" num="00013" class="claim">
      <div class="claim-text">13. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the distance is greater than 400 microns.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00014" num="00014" class="claim">
      <div class="claim-text">14. The method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the distance is greater than 600 microns.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00015" num="00015" class="claim">
      <div class="claim-text">15. A method of using a laser system, having a laser, to treat an eye having scleral tissue, having a thickness and a surface, the method comprising:
<div class="claim-text">using the laser to form a plurality of generally quadrilateral shaped matrices of pores, each matrix having a central hexagon, on the surface of the scleral tissue;</div>
<div class="claim-text">wherein the pores have inner walls that are spaced a distance from each another; and</div>
<div class="claim-text">filling each pore with a collagen-based scaffold.</div>
</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES40099201" lang="EN" load-source="patent-office" class="description">
    <heading>RELATED APPLICATION</heading> <p num="p-0002">The present application claims priority from U.S. Provisional Application No. 60/662,026, filed Mar. 15, 2005 herein incorporated by reference in its entirety.</p>
    <heading>TECHNICAL FIELD</heading> <p num="p-0003">The present invention relates to a system and method for treating connective tissue, and more specifically, to a system and method for treating connective tissue to alter the fundamental and biomechanical properties of the connective tissue.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p num="p-0004">Connective tissue is tissue that supports and connects other tissues and parts of the body. The fundamental and biomechanical properties of connective tissue, such as scleral tissue of the eye, may change as it ages. These fundamental and biomechanical properties include, but are not limited to, the structure, function, immunology, elasticity, shock absorption, resilience, mechanical dampening, pliability, stiffness, rigidity, configuration, alignment, deformation, mobility, volume, biochemistry and molecular genetics of connective tissue proper and newly metabolized connective tissue. The alterations of these properties may result in an accumulation of low grade stress/strain of the connective tissue. This can occur by acute injury or as a normal gradual process of aging. The alterations of these properties of connective tissue may change the overall desired properties of the connective tissue and may also undesirably affect the surrounding tissues, structures, organs, or systems related to the connective tissue. Examples of such undesirable affects are increased tension, loss of flexibility, contracture, fibrosis, or sclerosis, which can prevent the connective tissue or structures that are related to the connective tissue from performing their desired function.</p>
    <p num="p-0005">Alterations in fundamental and biomechanical properties, specifically its pliability and elasticity, of the scleral tissue of the eye may affect the ability of the eye to focus. These alterations of the scleral tissue may also contribute to an increase in the intraocular pressure and contribute to the loss of the contrast sensitivity of the eye or visual field of the eye. The biomechanical and structural alterations of the sclera may affect the refractive ability as well as the efficiency of the homeostatic functions of the eye such as intraocular pressure, aqueous production, pH balance, vascular dynamics, metabolism and eye organ function. Furthermore, these alterations of the scleral tissue may contribute to damage to the mechanoreceptors, photoreceptors, or sensory receptors in tissue layers and structures that are directly or indirectly related to the scleral tissue. Lastly, the fundamental and biomechanical alterations of the scleral tissue may also contribute to the ability of the cerebral cortex to process accurate visual stimulus necessary for processing visual signals into accurate visual perception.</p>
    <p num="p-0006">It is known to ablate the surface of scleral tissue of an eye. The surface of the scleral tissue may be ablated to form radially extending incisions or excisions. It is also known to form spots along a ring on the surface of scleral tissue by ablation. A plurality of bands, inserts, or plugs may be inserted into the scleral tissue of an eye to expand the sclera.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p num="p-0007">The present invention relates to a method of altering the properties of connective tissue including forming and maintaining pores or perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue. The connective tissue may be any desired connective tissue, such as scleral tissue of the eye. The connective tissue of the eye may be removed to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the outer diameter of the posterior surgical limbus of the eye. The first desired pattern of perforations may have a plurality of perforations. Connective tissue is removed from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the outer diameter of the posterior surgical limbus of the eye. The second desired pattern of perforations may have a plurality of perforations.</p>
    <p num="p-0008">The present invention also relates to a method of treating connective tissue. The method includes forming perforations in the connective tissue to at least 90% of the depth of the connective tissue. The method also includes at least partially affecting normal healing of the perforations.</p>
    <p num="p-0009">The present invention also relates to a method of treating connective tissue to improve the biomechanics of the tissue. Such improvements include, but are not limited to, increase in elasticity, shock absorption, pliability, structural integrity and/or mobility. The method includes removing connective tissue of an eye to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the outer diameter of the posterior surgical limbus of the eye, the first desired pattern of perforations having a plurality of perforations. The method also includes removing tissue from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the outer diameter of the posterior surgical limbus of the eye, the second desired pattern of perforations having a plurality of perforations.</p>
    <p num="p-0010">The present invention also relates to a system for treating connective tissue. The system include means for forming perforations in the connective tissue to at least 90% of the depth of the connective tissue. The system also includes means for at least partially affecting normal healing of the perforations.</p>
    <p num="p-0011">The present invention further relates to a system for treating connective tissue to increase elasticity of the tissue comprising. The system includes means for removing connective tissue of an eye to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the outer diameter of the posterior surgical limbus of the eye, the first desired pattern of perforations having a plurality of perforations. The system also includes means for removing tissue from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the outer diameter of the posterior surgical limbus of the eye, the second desired pattern of perforations having a plurality of perforations.</p>
    <description-of-drawings> <heading>BRIEF DESCRIPTION OF THE DRAWINGS</heading> <p num="p-0012">The foregoing and other features of the present invention will become apparent to one skilled in the art to which the present invention relates upon consideration of the following description of the invention with reference to the accompanying drawings, in which:</p>
      <p num="p-0013"> <figref idrefs="DRAWINGS">FIG. 1</figref> is a schematic drawing of a system of the present invention for use in treating connective tissue;</p>
      <p num="p-0014"> <figref idrefs="DRAWINGS">FIG. 2</figref> is a schematic pictorial view of an eye showing perforation patterns formed in connective tissue of the eye;</p>
      <p num="p-0015"> <figref idrefs="DRAWINGS">FIG. 2</figref> <i>a </i>is a schematic pictorial view of an eye showing perforation patterns formed in connective tissue of the eye;</p>
      <p num="p-0016"> <figref idrefs="DRAWINGS">FIG. 3</figref> is a schematic plan view of the eye of <figref idrefs="DRAWINGS">FIG. 2</figref> showing the perforation patterns formed in the connective tissue of the eye; and</p>
      <p num="p-0017"> <figref idrefs="DRAWINGS">FIG. 4</figref> is a schematic plan view of the eye of <figref idrefs="DRAWINGS">FIG. 2</figref> showing alternative perforation patterns formed in the connective tissue of the eye.</p>
    </description-of-drawings> <heading>DESCRIPTION OF EMBODIMENTS</heading> <p num="p-0018">A surgical laser system <b>10</b> for treating connective tissue is illustrated in <figref idrefs="DRAWINGS">FIG. 1</figref>. To treat the connective tissue, the system <b>10</b> accesses desired connective tissue. Access to the desired connective tissue can be done directly, such as by ablation. Also, access to the desired connective tissue can be done indirectly, such as by creating a flap, incision, excision, vaporization, or gap in overlying tissue or structure.</p>
    <p num="p-0019">The surgical laser system <b>10</b> may be used to treat any desired connective tissue of the body. For example, in the eye, the surgical laser system may be used to treat the conjunctiva; the cornea (including all its layers and membranes); the iris; the ciliary body; the ciliary muscles; the anterior chamber; the zonula ciliaris; the subchoroidal lamina; the extraocular muscles and their associated connective tissues, membranes, and fascia; the posterior chamber; the lens and all of its associated layers, tissues, capsules, and membranes; the canal of schlemm and all of its associated layers, tissues, capsules, and membranes; the ora seratta; the vitreous body; the papilla nervi optici; the optic nerve; the lamina cribrosa; the choroid; the sclera; the retina; all epithelial cell layers in the eye; the vascular structures in the eye; the accessory organs of the eye; and the lymph vessels of the eye.</p>
    <p num="p-0020">As another example, in the ear, the surgical laser system <b>10</b> may be used to treat the tympanic membrane, the crista ampullaris, the cochlear, the cochlear duct, and hair cells. As another example, the surgical laser system <b>10</b> may be used to treat tissue of the kidneys or tissue of the ovaries. As another example, the surgical laser system <b>10</b> may be used to treat large aponeuroses, such as lumbosacral fascia, abdominal raphe, and neural sheath in the spinal cord. As yet another example, the surgical laser system <b>10</b> may be used to treat bones, cartilage, ligaments, and tendons. As still another example, the surgical laser system <b>10</b> may be used to treat the brain, such as dura matter of the brain. As another example, the surgical laser system <b>10</b> may be used to treat lymph node CT or spleen CT. As another example, the surgical laser system <b>10</b> may be used to treat vascular vessels and the heart. As a further example, the surgical laser system <b>10</b> may be used to treat muscles.</p>
    <p num="p-0021">The surgical laser system <b>10</b> includes a laser <b>12</b> coupled to one end of a connector assembly <b>14</b>. An opposite end of the connector assembly <b>14</b> is connected to a hand-piece <b>16</b> having a tip <b>18</b>. The connector assembly <b>14</b> delivers laser energy from the laser <b>12</b> to the hand-piece <b>16</b>. The connector assembly <b>14</b> may be any desired assembly that delivers laser energy from the laser <b>12</b> to the hand-piece <b>16</b>, such as a fiber optic assembly, a collimated arm system, or an atomozied particle beam.</p>
    <p num="p-0022">The laser <b>12</b> may be any desired laser. For example, the laser <b>12</b> may be an Er:YAG laser having a wavelength of about 2.94 μm. The laser <b>12</b> may also be a free electron laser (FEL). The laser <b>12</b> may be any desired diode-pumped solid state laser, an infrared laser, an ultraviolet laser, or a semiconductor diode laser, an electromagnetic gas laser, or a femtosecond laser.</p>
    <p num="p-0023">The hand-piece <b>16</b> may include a laser head, such as an Er:YAG laser head, that is pumped by the laser <b>12</b> to generate and deliver laser radiation through the tip <b>18</b>. It is contemplated that the hand-piece <b>16</b> may be remotely connected with the laser <b>12</b>. The tip <b>18</b> may be a contact tip or a non-contact tip. It is contemplated that the tip <b>18</b> may be made of any desired material, such as quartz, sapphire, or any other rare or basic earth elements.</p>
    <p num="p-0024">The system <b>10</b> may also include a 2D or 3D scanning laser (not shown) for moving the laser radiation produced by the laser <b>12</b> in a desired pattern over the tissue. The system <b>10</b> may also incorporate a display, such as a holographic display or an LCD display. The system <b>10</b> may also incorporate robotic devices and/or components (not shown) for producing or controlling the radiation produced by the laser <b>12</b> or other device (not shown) in a desired pattern over the tissue. The system <b>10</b> may further incorporate operation via local or remote device. It is contemplated that the laser system <b>10</b> may include a scanning mechanism having a slit lamp and a gonioscope with or without the tip <b>18</b>.</p>
    <p num="p-0025">The system <b>10</b> may be used to remove any desired connective tissue by ablating the tissue. The desired connective tissue may be ablated to form perforations or pores in the connective tissue. Normal tissue healing is at least partially affected to maintain the perforations or pores in the connective tissue. By this, it is meant that the system <b>10</b> inhibits, disrupts, restricts, or otherwise causes the tissue to deviate from healing, repairing, or regenerating in a manner conforming to the usual or ordinary course of nature, producing observable deficiencies therein.</p>
    <p num="p-0026">The fundamental and biomechanical properties of the connective tissue may be improved by formation of the perforations. The formation of perforations interacts with and affects the fundamental mechanisms involved in the immunology, biochemistry and molecular genetics of connective tissue metabolism. Furthermore, tension or contracture in the connective tissue may be reduced. The connective tissue may be ablated to at least 90% of the depth or thickness of the connective tissue.</p>
    <p num="p-0027">The system <b>10</b> may ablate, excise, incise, vaporize, or puncture the tissue. This may be done along any axis, such as a transverse axis, sagital axis, frontal axis, or coronal axis with a single or plural repetitions (e.g., single or multiple ablations, excisions, incisions, vaporizations, or punctures). Alternatively, tension or contracture may be reduced by a shaving technique, with single or plural repetitions (e.g., single or multiple shavings) using various tips, to remove contiguous layers of tissue in desired areas. It is contemplated that the perforations may extend entirely through the depth or thickness of the tissue. If the perforations extend through the entire depth or thickness of the tissue, the perforated connective tissue may act as a flexible diaphragm pump.</p>
    <p num="p-0028">The system <b>10</b> may be used to ablate or remove connective tissue, such as scleral tissue, of an eye <b>20</b> (<figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>). A first desired pattern or matrix <b>22</b> of pores or perforations <b>24</b> is formed in the scleral tissue <b>26</b> of the eye <b>20</b>. The first pattern <b>22</b> of perforations <b>24</b> is formed at a first distance from the outer diameter of the posterior surgical limbus <b>28</b> of the eye <b>20</b>. The first distance is less than or equal to 1 mm from the outer diameter of the posterior surgical limbus of the eye <b>20</b>. The first pattern or matrix <b>22</b> of perforations <b>24</b> may have any desired number of perforations <b>24</b>.</p>
    <p num="p-0029">As shown in the embodiment of <figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>, the first pattern or matrix <b>22</b> of pores or perforations <b>24</b> may be a single, generally circular shaped pattern. It is contemplated that the first pattern <b>22</b> may have any desired shape. For example, the first pattern <b>22</b> may have a plurality of perforations <b>24</b> that form a cross-shaped pattern, a Z-shaped pattern, a U-shaped pattern, a V-shaped pattern, or an E-shaped pattern. It is also contemplated that the first pattern <b>22</b> may have perforations that form an oval, triangular, diamond, or rectangular shaped pattern or matrix.</p>
    <p num="p-0030">A second pattern or matrix <b>32</b> of pores or perforations <b>34</b> is formed in the scleral tissue <b>26</b> of the eye <b>20</b>. The second pattern <b>32</b> of perforations <b>34</b> is formed at a second distance from the outer diameter of the posterior surgical limbus <b>28</b> of the eye <b>20</b>. The second distance is greater than or equal to 1 mm and less than or equal to 4.5 mm from the outer diameter of the posterior surgical limbus of the eye <b>20</b>. The second pattern <b>32</b> of perforations <b>34</b> may have any desired number of perforations <b>34</b>.</p>
    <p num="p-0031">As shown in the embodiment of <figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>, the second pattern or matrix <b>32</b> of pores or perforations <b>34</b> include a plurality of generally circular patterns. The second pattern <b>32</b> includes seven such perforations <b>34</b> arranged in three parallel rows. The outer rows of perforations <b>34</b> include two perforations each and the middle row of perforations includes three perforations. As shown in <figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>, the perforations <b>34</b> of the middle row are offset from the perforations of the outer rows. It is contemplated that the second pattern or matrix <b>32</b> may have any desired shape. For example, the second pattern <b>32</b> may have a plurality of perforations <b>34</b> that form a cross-shaped pattern, a Z-shaped pattern, a U-shaped pattern, a V-shaped pattern, or an E-shaped pattern. It is also contemplated that the second pattern <b>32</b> may have perforations that form an oval, triangular, diamond, or rectangular shaped pattern or matrix.</p>
    <p num="p-0032">A third pattern or matrix <b>42</b> of pores or perforations <b>44</b> is formed in the scleral tissue <b>26</b> of the eye <b>20</b>. The third pattern or matrix <b>42</b> is substantially similar to the first and second patterns <b>22</b> and <b>32</b>. The third pattern <b>42</b> of perforations <b>44</b> is formed at a third distance from the outer diameter of the posterior surgical limbus <b>28</b> of the eye <b>20</b>. The third distance is greater than or equal to 4.5 mm from the outer diameter of the posterior surgical limbus of the eye <b>20</b>. The third pattern or matrix <b>42</b> of perforations <b>44</b> may have any desired number of perforations <b>44</b>.</p>
    <p num="p-0033">As shown in the embodiment of <figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>, the third pattern or matrix <b>42</b> of pores or perforations <b>44</b> may be a single circular shaped shaped pattern. It is contemplated that the third pattern <b>42</b> may have any desired shape. For example, the third pattern <b>42</b> may have a plurality of perforations <b>44</b> that form a cross-shaped pattern, a Z-shaped pattern, a U-shaped pattern, a V-shaped pattern, or an E-shaped pattern. It is also contemplated that the third pattern <b>42</b> may have perforations that form an oval, triangular, diamond, or rectangular shaped pattern.</p>
    <p num="p-0034">The first, second, and third patterns or matrices <b>22</b>, <b>32</b>, and <b>42</b> may have the same shape of have different shapes. The first, second, and third patterns <b>22</b>, <b>32</b>, and <b>42</b> (<figref idrefs="DRAWINGS">FIG. 3</figref>) are formed along the same radial line extending from the outer diameter of the posterior surgical limbus <b>28</b> of the eye <b>20</b>.</p>
    <p num="p-0035">The first, second and third patterns or matrices <b>22</b>, <b>32</b>, and <b>42</b> define a first set <b>52</b> of patterns or matrices. The first set <b>52</b> of patterns or matrices is formed in a first quadrant of the eye <b>20</b>. Second, third and fourth sets <b>54</b>, <b>56</b>, and <b>58</b> of patterns or matrices are formed in second, third, and fourth quadrants of the eye. The first, second, third, and fourth sets <b>52</b>, <b>54</b>, <b>56</b>, and <b>58</b> of patterns may be identical. The four sets <b>52</b>, <b>54</b>, <b>56</b>, and <b>58</b> of patterns each are arranged to have an overall diamond shape. It is contemplated that the first, second, third and fourth sets <b>54</b>, <b>54</b>, <b>56</b> and <b>58</b> may have a different number of patterns, differently shaped patterns, or a different number of perforations. It is contemplated that any desired number of sets of patterns of perforations may be formed in the scleral tissue <b>26</b> of the eye <b>20</b>.</p>
    <p num="p-0036">In <figref idrefs="DRAWINGS">FIGS. 2 and 3</figref>, the first, second, third and fourth sets <b>54</b>, <b>54</b>, <b>56</b> and <b>58</b> are located on the anterior portion <b>70</b> of the eye <b>20</b>. The sets <b>54</b>, <b>54</b>, <b>56</b> and <b>58</b> could, however, be located on the posterior of the eye <b>20</b>. This is shown in <figref idrefs="DRAWINGS">FIG. 2A</figref>. As shown in <figref idrefs="DRAWINGS">FIG. 2A</figref>, the first, second, third and fourth sets <b>54</b>, <b>54</b>, <b>56</b> and <b>58</b> are arranged on the posterior <b>72</b> of the eye <b>20</b>. As with the sets <b>54</b>, <b>54</b>, <b>56</b> and <b>58</b> on the anterior <b>70</b>, the sets on the posterior <b>70</b> of the eye <b>20</b> may have a different number of patterns or matrices, differently shaped patterns, or a different number of perforations.</p>
    <p num="p-0037">The pores or perforations <b>24</b>, <b>34</b>, and <b>44</b> may have any desired shape, such as cylindrical, pyramidal or tetrahedral. The perforations <b>24</b>, <b>34</b>, and <b>44</b> are formed to at least 90% of the depth or thickness of the scleral tissue <b>26</b>. The perforations <b>24</b>, <b>34</b>, and <b>44</b> may be formed entirely through the scleral tissue <b>26</b> to the subchoroidal lamina so that the scleral tissue may act as a diaphragm pump. The perforations <b>24</b>, <b>34</b>, and <b>44</b> are formed by moving the hand-piece <b>16</b> or any surgical tool in a direction toward the tissue without moving in a direction extending along the surface of the tissue. The movement is repeated until the desired depth of the perforation is achieved. The perforations <b>24</b>, <b>34</b>, and <b>44</b> may improve uveal-scleral aqueous flow to decrease the intraocular pressure of the eye <b>20</b>.</p>
    <p num="p-0038">The pores or perforations <b>24</b>, <b>34</b>, and <b>44</b> may have inner walls that are spaced from each other a distance that alters the fundamental mechanisms involved in the immunology, biochemistry and molecular genetics of connective tissue metabolism in such a way as to inhibit normal tissue healing, repair, or regeneration to prevent total healing of the perforations <b>24</b>, <b>34</b>, and <b>44</b> in the connective tissue. The inner walls of the perforations <b>24</b>, <b>34</b>, and <b>44</b> may be spaced from each other by a distance greater than 400 μm. It is also contemplated that the inner walls of the perforations <b>24</b>, <b>34</b>, and <b>44</b> may be spaced from each other by a distance greater than 600 μm.</p>
    <p num="p-0039">The perforations may be filled with a scarring inhibitor substance such as a porous collagen-glycosaminoglican scaffold. An example of such a porous collagen-glycosaminoglican scaffold is made by Mediking under the tradename OcculusGen. Alternatively, the perforations may be filled with a biological glycoprotein or a synthetic glycoprotein. As another alternative, the perforations may be filled via the application of a biologically compatible product, which can be in the form of a liquid, a gel, or a porous solid. The perforations may also be treated with a sealant. An examples of such a sealant is made by Johnson and Johnson under the tradename Band-Aid® brand liquid bandage; and a similar product is made by Spenco under the tradename 2<sup>nd </sup>Skin®. As a further alternative, the perforations may be filled via application or treatment to facilitate an ionic reaction, chemical reaction, photonic reaction, organic reaction, inorganic reaction, electronic reaction, or a combination of these reactions to disrupt normal tissue healing.</p>
    <p num="p-0040">Although the pores or perforations in the connective tissue have been described as being formed by ablating the tissue using laser energy, it is contemplated that the perforations could be formed using any desired surgical tool, such as a diamond knife, ruby knife, or a radio frequency device.</p>
    <p num="p-0041">An example of an alternative perforation patterns is illustrated in the embodiment shown in <figref idrefs="DRAWINGS">FIG. 4</figref>. The embodiment of <figref idrefs="DRAWINGS">FIG. 4</figref> is similar to the embodiment of <figref idrefs="DRAWINGS">FIGS. 1 and 2</figref>. Therefore, in <figref idrefs="DRAWINGS">FIG. 4</figref>, similar reference numbers are used, with the suffix “a” being used in <figref idrefs="DRAWINGS">FIG. 4</figref> for clarity.</p>
    <p num="p-0042">As shown in <figref idrefs="DRAWINGS">FIG. 4</figref>, the first pattern or matrix <b>22</b> <i>a </i>includes perforations <b>24</b> <i>a </i>that are arranged in a generally rectangular configuration. The first pattern <b>22</b> <i>a </i>extends generally radially from the from the outer diameter of the posterior surgical limbus <b>28</b> <i>a </i>of the eye <b>20</b> <i>a</i>. The second pattern or matrix <b>32</b> <i>a </i>includes three perforations <b>34</b> <i>a</i>, each of which are arranged in a generally rectangular configuration. Two of the perforations <b>34</b> <i>a </i>are positioned on opposite sides of the first pattern <b>22</b> <i>a</i>, extend parallel to the first pattern, and are offset longitudinally from the first pattern. A third perforation <b>34</b> <i>a </i>of the second pattern <b>32</b> <i>a </i>extends transverse (perpendicular) to the remaining two perforations and is positioned, and is positioned adjacent ends of the perforations of the other two perforations of the second pattern distal to the outer diameter of the posterior surgical limbus <b>28</b> <i>a </i>of the eye <b>20</b> <i>a. </i> </p>
    <p num="p-0043">The first and second patterns or matrices <b>22</b> <i>a </i>and <b>32</b> <i>a </i>define a first set <b>52</b> <i>a </i>of patterns or matrices. The first set <b>52</b> <i>a </i>of patterns is formed in a first quadrant of the eye <b>20</b> <i>a</i>. Second, third and fourth sets <b>54</b> <i>a</i>, <b>56</b> <i>a</i>, and <b>58</b> <i>a </i>of patterns or matrices are formed in second, third, and fourth quadrants of the eye <b>20</b> <i>a</i>. The first, second, third, and fourth sets <b>52</b> <i>a</i>, <b>54</b> <i>a</i>, <b>56</b> <i>a</i>, and <b>58</b> <i>a </i>of patterns may be identical. The four sets <b>52</b> <i>a</i>, <b>54</b> <i>a</i>, <b>56</b> <i>a</i>, and <b>58</b> <i>a </i>may have a different number of patterns, differently shaped patterns, or a different number of perforations. It is contemplated that any desired number of sets of patterns of perforations may be formed in the scleral tissue <b>26</b> <i>a </i>of the eye <b>20</b> <i>a</i>. Like the embodiment of <figref idrefs="DRAWINGS">FIGS. 2-3</figref>, the four sets <b>52</b> <i>a</i>, <b>54</b> <i>a</i>, <b>56</b> <i>a</i>, and <b>58</b> <i>a </i>of <figref idrefs="DRAWINGS">FIG. 4</figref> may be located on the anterior of the eye (shown), the posterior of the eye (not shown), or both.</p>
    <p num="p-0044">From the above, it will be appreciated that the present invention relates to a system for treating connective tissue. The system include means for forming perforations in the connective tissue to at least 90% of the depth of the connective tissue. The system also includes means for at least partially affecting normal healing of the perforations.</p>
    <p num="p-0045">It will also be appreciated that the present invention relates to a system for treating connective tissue to increase elasticity of the tissue comprising. The system includes means for removing connective tissue of an eye to form a first desired pattern of perforations in the connective tissue of the eye at a first distance from the outer diameter of the posterior surgical limbus of the eye, the first desired pattern of perforations having a plurality of perforations. The system also includes means for removing tissue from the eye to form a second desired pattern of perforations in the tissue of the eye at a second distance from the outer diameter of the posterior surgical limbus of the eye, the second desired pattern of perforations having a plurality of perforations.</p>
    <p num="p-0046">It will be understood that the above description of the present invention is susceptible to various modifications, changes and adaptations, and the same are intended to be comprehended within the meaning and range of equivalents of the appended claims. The presently disclosed embodiments are considered in all respects to be illustrative, and not restrictive. The scope of the invention is indicated by the appended claims, rather than the foregoing description, and all changes that come within the meaning and range of equivalence thereof are intended to be embraced therein.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5354331">US5354331</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 15, 1992</td><td class="patent-data-table-td patent-date-value">Oct 11, 1994</td><td class="patent-data-table-td ">Schachar Ronald A</td><td class="patent-data-table-td ">Treatment of presbyopia and other eye disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5653730">US5653730</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 1994</td><td class="patent-data-table-td patent-date-value">Aug 5, 1997</td><td class="patent-data-table-td ">Hemodynamics, Inc.</td><td class="patent-data-table-td ">Surface opening adhesive sealer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6254600">US6254600</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 11, 1999</td><td class="patent-data-table-td patent-date-value">Jul 3, 2001</td><td class="patent-data-table-td ">Arthrocare Corporation</td><td class="patent-data-table-td ">Systems for tissue ablation and aspiration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6263879">US6263879</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 10, 1998</td><td class="patent-data-table-td patent-date-value">Jul 24, 2001</td><td class="patent-data-table-td ">J. T. Lin</td><td class="patent-data-table-td ">Treatment of presbyopia and other eye disorders using a scanning laser system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20010016736">US20010016736</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 28, 2001</td><td class="patent-data-table-td patent-date-value">Aug 23, 2001</td><td class="patent-data-table-td ">Lin J. T.</td><td class="patent-data-table-td ">Methods and apparatus for presbyopia treatment using a scanning laser system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20010029363">US20010029363</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 30, 2001</td><td class="patent-data-table-td patent-date-value">Oct 11, 2001</td><td class="patent-data-table-td ">Lin J. T.</td><td class="patent-data-table-td ">Methods and apparatus for presbyopia correction using ultraviolet and infrared lasers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030028228">US20030028228</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2002</td><td class="patent-data-table-td patent-date-value">Feb 6, 2003</td><td class="patent-data-table-td ">Sand Bruce J.</td><td class="patent-data-table-td ">Treatment of collagen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030059755">US20030059755</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 2002</td><td class="patent-data-table-td patent-date-value">Mar 27, 2003</td><td class="patent-data-table-td ">D&#39;amico Donald J.</td><td class="patent-data-table-td ">Laminar cribosa puncture device, methods related to use of such a device and methods for treating central retinal vein occulsions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20030220630">US20030220630</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 12, 2002</td><td class="patent-data-table-td patent-date-value">Nov 27, 2003</td><td class="patent-data-table-td ">Jui-Teng Lin</td><td class="patent-data-table-td ">Methods and systems for treating presbyopia via laser ablation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20050107774">US20050107774</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 2, 2004</td><td class="patent-data-table-td patent-date-value">May 19, 2005</td><td class="patent-data-table-td ">Lin J. T.</td><td class="patent-data-table-td ">Methods and apparatus for presbyopia correction using ultraviolet and infrared lasers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20050205101">US20050205101</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 22, 2005</td><td class="patent-data-table-td patent-date-value">Sep 22, 2005</td><td class="patent-data-table-td ">Lin J T</td><td class="patent-data-table-td ">Combined pharmocological and surgical method and system for the treatment of eye disorders</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20050279369">US20050279369</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 21, 2004</td><td class="patent-data-table-td patent-date-value">Dec 22, 2005</td><td class="patent-data-table-td ">Lin J T</td><td class="patent-data-table-td ">Method and apparatus for the treatment of presbyopia and glaucoma by ciliary body ablation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20070225631">US20070225631</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 6, 2003</td><td class="patent-data-table-td patent-date-value">Sep 27, 2007</td><td class="patent-data-table-td ">Bowlin Gary L</td><td class="patent-data-table-td ">Sealants for Skin and Other Tissues</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc606/defs606.htm&usg=AFQjCNEEvaL03g4JHfjHz3wZXhk_WBlsyw#C606S005000">606/5</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc128/defs128.htm&usg=AFQjCNGjl9q_l-XTxZ44q3zsgsK3JYPF-w#C128S898000">128/898</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc606/defs606.htm&usg=AFQjCNEEvaL03g4JHfjHz3wZXhk_WBlsyw#C606S004000">606/4</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0018200000">A61B18/20</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2009/00865">A61F2009/00865</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F9/00825">A61F9/00825</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F9/008">A61F9/008</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F9/00821">A61F9/00821</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=pwC4BgABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F9/00802">A61F9/00802</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61F9/008</span>, <span class="nested-value">A61F9/008C</span>, <span class="nested-value">A61F9/008A</span>, <span class="nested-value">A61F9/008D</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Jun 2, 2014</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 4, 2014</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20131219</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 24, 2013</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIM 15 IS CONFIRMED.CLAIMS 1-14 ARE CANCELLED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 22, 2011</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20110915</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 2, 2011</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ACE VISION EURO, LTD, UNITED KINGDOM</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HIPSLEY, ANNMARIE;REEL/FRAME:025886/0914</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071001</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 25, 2010</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HIPSLEY, ANN MARIE;CAMRAS, LUCINDA J.;REEL/FRAME:024888/0009</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ACE VISION EURO, LTD, UNITED KINGDOM</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071001</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_4ff636b3d23669b7103f3b3a3a18b4cd.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0fphSJCaxB9tWYRXeHjI2fYOXFSA\u0026id=pwC4BgABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3fzS1eM9jOkGLGiBOaqsL3T8jXbg\u0026id=pwC4BgABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U03GzGPmM8Xg98xt5nN8HT4bVQbkg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/System_and_method_for_treating_connectiv.pdf?id=pwC4BgABERAJ\u0026output=pdf\u0026sig=ACfU3U3KT-Y4eRLgWBUsAWPzJvTkvoIaUQ"},"sample_url":"http://www.google.com/patents/reader?id=pwC4BgABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>